{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T22:33:33Z","timestamp":1782254013975,"version":"3.54.5"},"reference-count":29,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2008,6,1]],"date-time":"2008-06-01T00:00:00Z","timestamp":1212278400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2008,6]]},"DOI":"10.1016\/j.prp.2008.01.012","type":"journal-article","created":{"date-parts":[[2008,3,15]],"date-time":"2008-03-15T14:58:19Z","timestamp":1205593099000},"page":"367-371","source":"Crossref","is-referenced-by-count":10,"title":["Apocrine carcinomas of the breast in Turkish women: Hormone receptors, c-erbB-2 and p53 immunoexpression"],"prefix":"10.1016","volume":"204","author":[{"given":"Handan","family":"Kaya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00fcheyla Uyar","family":"Bozkurt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u0130pek","family":"Erbarut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustafa B.A.","family":"Djamgoz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.prp.2008.01.012_bib1","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1038\/nm0796-811","article-title":"Specific p53 mutations are associated with de novo resistance to doxorubicin in breast cancer patients","volume":"2","author":"Aas","year":"1996","journal-title":"Nat. Med."},{"key":"10.1016\/j.prp.2008.01.012_bib2","first-page":"341","article-title":"Problems in breast pathology","volume":"11","author":"Azzopardi","year":"1979","journal-title":"Major Probl. Pathol."},{"key":"10.1016\/j.prp.2008.01.012_bib3","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1097\/00019606-200206000-00008","article-title":"Androgen and estrogen receptor mRNA status in apocrine carcinomas","volume":"11","author":"Bratthauer","year":"2002","journal-title":"Diagn. Mol. Pathol."},{"key":"10.1016\/j.prp.2008.01.012_bib4","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1002\/1097-0142(19841201)54:11<2436::AID-CNCR2820541121>3.0.CO;2-H","article-title":"Androgen receptors in breast cancer","volume":"54","author":"Bryan","year":"1984","journal-title":"Cancer"},{"key":"10.1016\/j.prp.2008.01.012_bib5","doi-asserted-by":"crossref","first-page":"2935","DOI":"10.1016\/j.febslet.2006.03.080","article-title":"Molecular pathology of breast carcinomas: a protein expression signature specific for benign apocrine metaplasia","volume":"580","author":"Celis","year":"2006","journal-title":"FEBS Lett."},{"key":"10.1016\/j.prp.2008.01.012_bib6","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1002\/1097-0142(196804)21:4<756::AID-CNCR2820210428>3.0.CO;2-Y","article-title":"Carcinoma of the breast. Histologic and clinical features of apocrine tumors","volume":"21","author":"Frable","year":"1968","journal-title":"Cancer"},{"key":"10.1016\/j.prp.2008.01.012_bib7","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1136\/jcp.2006.044701","article-title":"Frequency and reliability of oestrogen receptor, progesterone receptor and HER2 in breast carcinoma determined by immunohistochemistry in Australasia: results of the RCPA quality assurance program","volume":"60","author":"Francis","year":"2007","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.prp.2008.01.012_bib8","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/S0344-0338(97)80053-2","article-title":"Immunohistochemical analysis of apocrine breast lesions. Consistent over-expression of androgen receptor accompanied by the loss of estrogen and progesterone receptors in apocrine metaplasia and apocrine carcinoma in situ","volume":"193","author":"Gatalica","year":"1997","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.prp.2008.01.012_bib9","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1749-6632.1990.tb17804.x","article-title":"Review of GCDFP-15 an apocrine marker protein","volume":"586","author":"Haagensen","year":"1990","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.prp.2008.01.012_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/(SICI)1098-1004(1999)14:1<1::AID-HUMU1>3.0.CO;2-H","article-title":"IARC p53 mutation database: a relational database to compile and analyze p53 mutations in human tumors and cell lines","volume":"14","author":"Hernandez-Boussard","year":"1999","journal-title":"Int. Agency Res. Cancer. Hum. Mutat."},{"key":"10.1016\/j.prp.2008.01.012_bib11","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1046\/j.1365-2559.2003.01542.x","article-title":"Breast carcinoma in women over the age of 85: distinct histological pattern and androgen, oestrogen and progesterone receptor status","volume":"42","author":"Honma","year":"2003","journal-title":"Histopathology"},{"key":"10.1016\/j.prp.2008.01.012_bib12","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/j.1365-2559.2005.02181.x","article-title":"Expression of GCDFP-15 and AR decreases in larger or node-positive apocrine carcinomas of the breast","volume":"47","author":"Honma","year":"2005","journal-title":"Histopathology"},{"key":"10.1016\/j.prp.2008.01.012_bib13","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.breast.2004.06.003","article-title":"Pure invasive apocrine carcinoma of the breast: a new clinicopathological entity?","volume":"14","author":"Japaze","year":"2005","journal-title":"The Breast"},{"key":"10.1016\/j.prp.2008.01.012_bib14","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1053\/hupa.2001.24327","article-title":"Apocrine ductal carcinoma in situ of the breast: histologic classification and expression of biologic markers","volume":"32","author":"Leal","year":"2001","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.prp.2008.01.012_bib15","first-page":"91","article-title":"Apocrine differentiation in invasive carcinomas of the breast. Comparison of monoclonal and polyclonal gross cystic disease fluid protein 15 with prolactin inducible protein in RNA gene expression","volume":"3","author":"Losi","year":"1995","journal-title":"Appl. Immunohistochem."},{"key":"10.1016\/j.prp.2008.01.012_bib16","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1023\/A:1026439204849","article-title":"The basic pathology of human breast cancer","volume":"5","author":"Mallon","year":"2000","journal-title":"J. Mammary Gland Biol. Neoplasia"},{"key":"10.1016\/j.prp.2008.01.012_bib17","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1002\/1097-0142(19801215)46:12+<2838::AID-CNCR2820461421>3.0.CO;2-A","article-title":"Estrogen and progesterone receptors in the prediction of response of breast cancer to endocrine therapy","volume":"46","author":"Manni","year":"1980","journal-title":"Cancer"},{"key":"10.1016\/j.prp.2008.01.012_bib18","first-page":"268","article-title":"Apocrine carcinoma of the breast presenting as a solitary cyst: cytological and histopathological study of a case","volume":"47","author":"Mardi","year":"2004","journal-title":"Indian J. Pathol. Microbiol."},{"key":"10.1016\/j.prp.2008.01.012_bib19","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1002\/cncr.11532","article-title":"Androgen receptors frequently are expressed in breast carcinomas, potential relevance to new therapeutic strategies","volume":"98","author":"Moinfar","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.prp.2008.01.012_bib20","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1111\/j.1600-0463.2006.apm_321.x","article-title":"Expression of androgen receptors and inhibin\/activin alpha and betaA subunits in breast apocrine lesions","volume":"114","author":"Park","year":"2006","journal-title":"APMIS"},{"key":"10.1016\/j.prp.2008.01.012_bib21","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1093\/annonc\/mdl296","article-title":"Clinical outcome of adjuvant endocrine treatment according to PR and HER-2 status in early breast cancer","volume":"17","author":"Ponzone","year":"2006","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.prp.2008.01.012_bib22","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.1002\/cncr.21919","article-title":"The impact of tumor progesterone receptor status on optimal adjuvant endocrine therapy for postmenopausal patients with early-stage breast cancer: a decision analysis","volume":"106","author":"Punglia","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.prp.2008.01.012_bib23","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1136\/jcp.53.9.688","article-title":"Frequency of oestrogen and progesterone receptor positivity by immunohistochemical analysis in 7016 breast carcinomas: correlation with patient age, assay sensitivity, threshold value, and mammographic screening","volume":"53","author":"Rhodes","year":"2000","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.prp.2008.01.012_bib24","doi-asserted-by":"crossref","first-page":"325","DOI":"10.5858\/2002-126-0325-MSOERN","article-title":"Morphologic spectrum of estrogen receptor-negative breast carcinoma","volume":"126","author":"Scawn","year":"2002","journal-title":"Arch. Pathol. Lab. Med."},{"key":"10.1016\/j.prp.2008.01.012_bib25","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s10549-004-9495-z","article-title":"Clinicopathological feature and long-term prognosis of apocrine carcinoma of the breast in Japanese women","volume":"88","author":"Takeuchi","year":"2004","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.prp.2008.01.012_bib26","unstructured":"F.A. Tavassoli, P. Devilee, Invasive breast carcinoma, in: I.O. Ellis, S.J. Schnitt, X. Sastre-Garau, G. Bussolati, F.A. Tavassoli, V. Eusebi, J.L. Peterse, K. Mukai, L. Tabar, J. Jacquemier (Eds.), WHO Pathology and Genetics Tumours of the Breast and Female Genital Organs, IARC Press, Lyon, 2003, pp. 36\u201337, 56\u201359."},{"key":"10.1016\/j.prp.2008.01.012_bib27","doi-asserted-by":"crossref","first-page":"4660","DOI":"10.1038\/sj.onc.1208561","article-title":"Identification of molecular apocrine breast tumours by microarray analysis","volume":"24","author":"Tubiana-Hulin","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.prp.2008.01.012_bib28","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1200\/JCO.20.3.719","article-title":"Efficacy and safety of trastuzumab as a single agent in first-line treatment of HER2-overexpressing metastatic breast cancer","volume":"20","author":"Vogel","year":"2002","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.prp.2008.01.012_bib29","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s00428-005-0095-z","article-title":"The enigmatic nature of apocrine breast lesions","volume":"448","author":"Zagorianakou","year":"2006","journal-title":"Virchows Arch."}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033808000265?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033808000265?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,9,5]],"date-time":"2021-09-05T23:47:20Z","timestamp":1630885640000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033808000265"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,6]]},"references-count":29,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2008,6]]}},"alternative-id":["S0344033808000265"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2008.01.012","relation":{},"ISSN":["0344-0338"],"issn-type":[{"value":"0344-0338","type":"print"}],"subject":[],"published":{"date-parts":[[2008,6]]}}}